IPSS-M outperforms IPSS-R in prognostic stratification and guides effective interventions for very High-Risk myelodysplastic syndrome patients undergoing allogeneic hematopoietic stem cell transplantation
Abstract Allogeneic hematopoietic stem cell transplantation represents a curative modality for patients with myelodysplastic syndrome (MDS), yet relapse risk persists. The prognostic performances of the Revised International Prognostic Scoring System (IPSS-R) and the Molecular International Prognost...
Saved in:
| Main Authors: | Huixian Wu, Shuang Li, Jun Yang, Yu Cai, Huiying Qiu, Chongmei Huang, Yin Tong, Kun Zhou, Jiahua Niu, Xinxin Xia, Ying Zhang, Xiaowei Xu, Chang Shen, Baoxia Dong, Liping Wan, Xianmin Song |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-07-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-03155-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Validation and comparison of the molecular international prognostic scoring system (IPSS-M) and the revised international prognostic scoring system (IPSS-R) in myelodysplastic neoplasms (MDS): a retrospective study
by: Mengmeng Hu, et al.
Published: (2025-12-01) -
The AST/ALT (De Ritis) ratio as a significant prognostic factor in myelodysplastic syndrome
by: Ying Chen, et al.
Published: (2024-12-01) -
Correlation of Uroflowmetry with Prostate Volume and International Prostatic Symptom Score (IPSS)
by: Iffat Raza, et al.
Published: (2022-10-01) -
Association between lymphocyte-associated ratios, C-reactive protein and prognostic value in myelodysplastic syndromes
by: Hong-kai Cai, et al.
Published: (2025-12-01) -
Real-World Treatment Patterns, Clinical Outcomes, and Costs in Patients with Higher-Risk Myelodysplastic Syndromes Across France, Germany, and the United Kingdom
by: Drummond M, et al.
Published: (2025-06-01)